Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes

Abstract

Recently, solid lipid nanoparticles (SLNs) have attracted increasing attention owing to their potential as an oral delivery system, promoting intestinal absorption in the lymphatic circulation which plays a role in disseminating metastatic cancer cells and infectious agents throughout the body. SLN features can be exploited for the oral delivery of theranostics. Therefore, the aim of this work was to design and characterise self-assembled lipid nanoparticles (SALNs) to encapsulate and stabilise iron oxide nanoparticles non-covalently coated with heparin (Fe@hepa) as a model of a theranostic tool. SALNs were characterised for physico-chemical properties (particle size, surface charge, encapsulation efficiency, in vitro stability, and heparin leakage), as well as in vitro cytotoxicity by methyl thiazole tetrazolium (MTT) assay and cell internalisation in CaCo-2, a cell line model used as an indirect indication of intestinal lymphatic absorption. SALNs of about 180 nm, which are stable in suspension and have a high encapsulation efficiency (>90%) were obtained. SALNs were able to stabilise the heparin coating of Fe@hepa, which are typically unstable in physiological environments. Moreover, SALNs–Fe@hepa showed no cytotoxicity, although their ability to be internalised into CaCo-2 cells was highlighted by confocal microscopy analysis. Therefore, the results indicated that SALNs can be considered as a promising tool to orally deliver theranostic Fe@hepa into the lymphatic circulation, although further in vivo studies are needed to comprehend further potential applications.

Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma

“…Thus, the in vitro cytotoxicity of DDS NPs was all due to the drugs which were coencapsulated in the NPs. The results were matched with other combined nanocarriers reported [48][49][50].…”

Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells

“…Upon cooling, pre-emulsion has smaller droplets, which may result in smaller nanoparticles. It was observed that the cellular uptake and distribution of SLNs were influenced by the particle size, surface charge, type of lipids, and the concentration of the emulsion [ 19 , 20 ]. TEM imaging confirmed that the synthesized Res-SLNs were spherical with a narrow size distribution.…”

Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy

“…The in vitro study on MCF7/Adr cells and liver cancer H22 cells showed DOX-ERLP can cause cancer cell death efficiently, 75 and the in vivo study on H22-bearing mice presented an obvious cancer cell apoptosis and necrosis compared with control groups. 75 Recently, Truzzi et al focused on the antitumor effects through lymphatic circulation, using solid lipid nanoparticles (SLNs) to encapsulate iron oxide nanoparticles and heparin, to simulate the intestinal lymphatic absorption of oral administration in CaCo-2 cells; 76 this approach demonstrates that SLNs can be used as an important route of delivery for oral administration. Zhang et al designed lipid-coated zinc phosphate hybrid nanoparticles coupled with vaccine based on the specific immune response in vivo, in order to transfer peptide and adjuvant to achieve tumor immunotherapy.…”